Comparison

Meseclazone European Partner

Item no. HY-U00157-1mg
Manufacturer MedChem Express
CASRN 29053-27-8
Amount 1mg
Quantity options 100 mg 10mg 1 ea 1mg 20mg 5mg
Category
Type Inhibitors
Specific against other
Citations [1]Diamantis W, et al. Meseclazone, 5-chlorosalicylic acid and acetylsalicylic acid. Comparison of their effects on in vitro and ex vivo platelet aggregation. Thromb Haemost. 1978 Aug 31;40(1):24-36.<br/>[2]Diamantis W, et al. Antagonism by meseclazone and other nonsteroidal anti-inflammatory drugs of bradykinin-induced bronchospasm. Pharmacology. 1982;24(4):243-7.
Smiles O=C1N(OC(C)C2)C2OC3=CC=C(Cl)C=C13
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias W2395; NSC297623
Available
Product Description
Meseclazone (W2395; NSC297623) exhibits inhibitory potency of secondary phase ADP aggregation. Meseclazone possesses anti-inflammatory, analgesic and antipyretic activity.
Shipping
Room temperature
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
239.66
Clinical Information
No Development Reported
Manufacturers Research Area
Inflammation/Immunology
Solubility
10 mM in DMSO
Target
Others
Manufacturers Target
Others
Manufacturers Pathway
Others
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close